<DOC>
<DOCNO>en.15.227.44.2007.12.11</DOCNO>
<TITLE> European stocks turn flat; Fed eyed </TITLE>
<TEXT>
 LONDON, Dec 11 (bdnews24.com/Reuters) - European shares gave up gains to trade flat early on Tuesday, as losses in defensive pharma stocks offset the impact of consolidation talk in miners and investors turned their focus to a US rate decision. At 0839 GMT, the FTSEurofirst 300 index of top European shares was flat at 1,547.14 points. Miner Xstrata gained 3.2 percent after the Financial Times reported, citing people close to the situation, that it was open to discussions with potential suitors. Xstrata declined comment. But drug stocks GlaxoSmithKline, AstraZeneca and Sanofi Aventis lost between 0.7 and 1.2 percent as investors switched out of defensives. Financial markets are betting that the Fed will lower the benchmark federal funds rate by 25 basis points to 4.25 percent, and think a half-point reduction is not out of the question. A 25-basis point cut will take the Fed's easing since September to a full percentage poi
</TEXT>
</DOC>
